Анализ ассортимента пероральных сахароснижающих препаратов на фармацевтическом рынке Украины и их наличия в нормативных документах: унифицированном клиническом протоколе и международных рекомендациях Global Guideline for Type 2 Diabetes

Abstract

Analysis of normative documents: a standardized clinical protocol (Ukraine, 2012) and international clinical guidelines (Global guideline for type 2 diabetes, 2012), showed that the documents have only one difference. Standardized clinical protocol includes meglіnіdis, which are not included in international clinical guidelines (Global Guideline for Type 2 diabetes). These drugs have some advantages: effective control of postprandial hyperglycemia, fast onset of action, can be used in patients with irregular feeding nutrition. But these drugs do not have the evidence about their long-term effectiveness and safety. In accordance with this, Ukraine's health system can provide a high quality of health care for patients with type 2 diabetes, that confirms to modern requirements of use of safe and effective therapy. Ukrainian pharmaceutical market offers a wide variety of oral antidiabetic medicines in different price ranges.